Analytical interpretations of structural and mechanical response of high density polyethylene/hydroxyapatite bio-composites

Ultra-high molecular weight polyethylene bioactive composites with carbonated hydroxyapatite

To develop an orthopedic material for bone substitution, the substitute material must mimic living tissue from an anatomical and physiological point of view. The high wear and impact resistance besides the low friction coefficient, make ultra-high molecular weight polyethylene (UHMWPE) a suitable material to be used in orthopedic applications. However, UHMWPE is a bioinert material, not providing a proper interaction with the bone tissue surrounding to the implant. One way to mitigate this issue is improving UHMWPE bioactivity. This can be done by adding bioactive fillers in the polymeric matrix. In this work, UHMWPE composites were prepared by twin-screw extrusion. The fillers used were carbonated hydroxyapatite (CHA) and hybrids formed by precipitating CHA in collagens (hydrolyzed and type II). The results show that the fillers used caused a slight reduction in UHMWPE crystallinity degree, while both crystallization and melting temperatures remained almost unchanged. Dynamic-mechanical thermal analysis indicated a weak adhesion between filler and polymeric matrix, which is good from the biological point of view since the bioactive filler surface will be available to apatite deposition. The obtained materials exhibited good mechanical properties and in vitro bioactivity assay showed that all of the prepared materials are bioactive.

Bone-like Polymeric Composites with a Combination of Bioactive Glass and Hydroxyapatite: Simultaneous Enhancement of Mechanical Performance and Bioactivity

An ideal bone substitute requires not only high bioactivity but also sufficient mechanical performance, which is however inaccessible due to the lack of rational structure and composition design. Here, bioactive glass (BG)/hydroxyapatite (HA)/polyethylene (PE) composites with bone-like structure were prepared via a structuring injection molding. The strong and reciprocating shear field offered by the modified injection molding induced plenty of interlocked shish kebabs, mimicking the aligned collagen fibers in the natural bone. Such a bone-like structure enhanced the strength and toughness of the BG/HA/PE composites simultaneously, compensating the mechanical loss caused by the presence of BG. In vitro cell culture assays demonstrated that the combination of BG and HA significantly promoted cell attachment, proliferation, and alkaline phosphatase activity compared to the use of HA alone. It was attributed to upregulated expression of β-catenin stimulated by BG. The mineralization in simulated body fluid revealed that the BG/HA/PE composite exhibited apatite-forming ability stronger than that of the HA/PE counterpart. The integration of excellent mechanical performance and high bioactivity demonstrated the significant potential of the structured BG/HA/PE composites as load-bearing bone substitutes.

Synthesis and characterization of novel elastomeric poly(D,L-lactide urethane) maleate composites for bone tissue engineering

Here, we report the synthesis and characterization of a novel 4-arm poly(lactic acid urethane)-maleate (4PLAUMA) elastomer and its composites with nano-hydroxyapatite (nHA) as potential weight-bearing composite. The 4PLAUMA/nHA ratios of the composites were 1:3, 2:5, 1:2 and 1:1. FTIR and NMR characterization showed urethane and maleate units integrated into the PLA matrix. Energy dispersion and Auger electron spectroscopy confirmed homogeneous distribution of nHA in the polymer matrix. Maximum moduli and strength of the composites of 4PLAUMA/nHA, respectively, are 1973.31 ± 298.53 MPa and 78.10 ± 3.82 MPa for compression, 3630.46 ± 528.32 MPa and 6.23 ± 1.44 MPa for tension, 1810.42 ± 86.10 MPa and 13.00 ± 0.72 for bending, and 282.46 ± 24.91 MPa and 5.20 ± 0.85 MPa for torsion. The maximum tensile strains of the polymer and composites are in the range of 5% to 93%, and their maximum torsional strains vary from 0.26 to 0.90. The composites exhibited very slow degradation rates in aqueous solution, from approximately 50% mass remaining for the pure polymer to 75% mass remaining for composites with high nHA contents, after a period of 8 weeks. Increase in ceramic content increased mechanical properties, but decreased maximum strain, degradation rate, and swelling of the composites. Human bone marrow stem cells and human endothelial cells adhered and proliferated on 4PLAUMA films and degradation products of the composites showed little-to-no toxicity. These results demonstrate that novel 4-arm poly(lactic acid urethane)-maleate (4PLAUMA) elastomer and its nHA composites may have potential applications in regenerative medicine.